ArticleBiochemical and biophysical research communications2012

Increased expression of bHLH transcription factor E2A (TCF3) in prostate cancer promotes proliferation and confers resistance to doxorubicin induced apoptosis.

Divya Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.